Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (49) 49
humans (26) 26
female (21) 21
male (19) 19
plant sciences (18) 18
plants (13) 13
research (11) 11
adult (10) 10
analysis (10) 10
biochemistry & molecular biology (10) 10
middle aged (10) 10
proteins (10) 10
dehydration (9) 9
aged (8) 8
desiccation (8) 8
genes (8) 8
water - metabolism (8) 8
abridged index medicus (7) 7
arabidopsis-thaliana (7) 7
gene expression (7) 7
adolescent (6) 6
base sequence (6) 6
cell biology (6) 6
desiccation tolerance (6) 6
gene expression regulation, plant (6) 6
physiological aspects (6) 6
risk (6) 6
abscisic-acid (5) 5
adaptation, physiological (5) 5
arabidopsis - genetics (5) 5
article (5) 5
cardiovascular disease (5) 5
child (5) 5
child, preschool (5) 5
drought (5) 5
expression (5) 5
food and beverages (5) 5
journal article (5) 5
life sciences (5) 5
magnoliopsida - genetics (5) 5
management (5) 5
medical research (5) 5
methods (5) 5
molecular sequence data (5) 5
plant proteins - genetics (5) 5
resurrection plants (5) 5
studies (5) 5
age (4) 4
amino acid sequence (4) 4
animals (4) 4
arabidopsis - enzymology (4) 4
arabidopsis proteins - metabolism (4) 4
arabidopsis thaliana (4) 4
cancer (4) 4
cardiovascular diseases (4) 4
cerebral infarction (4) 4
complementary dna (4) 4
craterostigma - genetics (4) 4
craterostigma-plantagineum (4) 4
enzymes (4) 4
genes, plant (4) 4
genetic research (4) 4
genomics (4) 4
genotype (4) 4
leaves (4) 4
magnoliopsida - metabolism (4) 4
mortality (4) 4
mutation (4) 4
myocardial infarction (4) 4
pediatrics (4) 4
phospholipase d - genetics (4) 4
phospholipase d - metabolism (4) 4
plant proteins - metabolism (4) 4
public, environmental & occupational health (4) 4
resurrection plant (4) 4
risk factors (4) 4
risk-factors (4) 4
seedlings (4) 4
stress tolerance (4) 4
abscisic acid - pharmacology (3) 3
agriculture (3) 3
alleles (3) 3
arabidopsis (3) 3
arabidopsis proteins - genetics (3) 3
barley (3) 3
biology (3) 3
birth weight (3) 3
cardiovascular diseases - prevention & control (3) 3
children (3) 3
cohort studies (3) 3
craterostigma - metabolism (3) 3
dehydration tolerance (3) 3
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (3) 3
dna primers - genetics (3) 3
dna, complementary - genetics (3) 3
dna, plant - genetics (3) 3
double-blind method (3) 3
drought stress (3) 3
drugs (3) 3
follow-up studies (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Earth Sciences (Noranda) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Law (Bora Laskin) - Stacks (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
Robarts - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases
by Wang, SV and Verpillat, P and Rassen, JA and Patrick, A and Garry, EM and Bartels, DB
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 03/2016, Volume 99, Issue 3, pp. 325 - 332
The scientific community and decision‐makers are increasingly concerned about transparency and reproducibility of epidemiologic studies using longitudinal... 
RISK | PHARMACOLOGY & PHARMACY | SECONDARY DATA SOURCES | INHIBITORS | DRUGS | Reproducibility of Results | Observational Studies as Topic - standards | Humans | Access to Information | Cohort Studies | Databases, Factual | Pharmacoepidemiology - standards | Decision-making | Usage | Electronic records | Medical care | Management | Research | Epidemiology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
by Eikelboom, John W and Connolly, Stuart J and Bosch, Jackie and Dagenais, Gilles R and Hart, Robert G and Shestakovska, Olga and Diaz, Rafael and Alings, Marco and Lonn, Eva M and Anand, Sonia S and Widimsky, Petr and Hori, Masatsugu and Avezum, Alvaro and Piegas, Leopoldo S and Branch, Kelley R.H and Probstfield, Jeffrey and Bhatt, Deepak L and Zhu, Jun and Liang, Yan and Maggioni, Aldo P and Lopez-Jaramillo, Patricio and O’Donnell, Martin and Kakkar, Ajay K and Fox, Keith A.A and Parkhomenko, Alexander N and Ertl, Georg and Störk, Stefan and Keltai, Matyas and Ryden, Lars and Pogosova, Nana and Dans, Antonio L and Lanas, Fernando and Commerford, Patrick J and Torp-Pedersen, Christian and Guzik, Tomek J and Verhamme, Peter B and Vinereanu, Dragos and Kim, Jae-Hyung and Tonkin, Andrew M and Lewis, Basil S and Felix, Camilo and Yusoff, Khalid and Steg, P. Gabriel and Metsarinne, Kaj P and Cook Bruns, Nancy and Misselwitz, Frank and Chen, Edmond and Leong, Darryl and Yusuf, Salim and COMPASS Investigators
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
In patients with stable cardiovascular disease, those receiving rivaroxaban plus aspirin had fewer major cardiovascular events but more major bleeding events... 
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | ORAL RIVAROXABAN | CLOPIDOGREL | SECONDARY PREVENTION | Atherosclerosis - drug therapy | Double-Blind Method | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Atherosclerosis - complications | Male | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Aspirin | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Research | Cardiovascular diseases | Drug therapy | Observations | Methods | Myocardial infarction | Cerebral infarction | Medical research | Cardiovascular disease | Bleeding | Studies | Disease prevention | Arteriosclerosis | Coronary vessels | Atherosclerosis | Drug dosages | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
by Schwartz, Gregory G and Steg, P. Gabriel and Szarek, Michael and Bhatt, Deepak L and Bittner, Vera A and Diaz, Rafael and Edelberg, Jay M and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J. Wouter and Lecorps, Guillaume and Mahaffey, Kenneth W and Moryusef, Angèle and Pordy, Robert and Quintero, Kirby and Roe, Matthew T and Sasiela, William J and Tamby, Jean-François and Tricoci, Pierluigi and White, Harvey D and Zeiher, Andreas M and ODYSSEY OUTCOMES Comm Inv and ODYSSEY OUTCOMES Committees and Investigators
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Apolipoproteins | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights